NIH-funded research NIH-funded research

A data repository for HIV pharmacology

Official title: HIV Pharmacology Data Repository

Funded at Univ of North Carolina Chapel Hill · NIH-11010806 · Data updated 2026-11-12

This study is working to gather and organize a huge amount of information about HIV treatments to help researchers find better ways to help patients like you, making it easier for them to discover new and improved treatment options.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJanuary 12, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$497,208
NIH project number5U24AI181685-02
Project IDNIH-11010806 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals living with HIV or those at high risk of HIV infection.

Less likely to help

Patients who are not affected by HIV or are not at risk for HIV infection may not receive any benefit from this research.

What this research studies

This research focuses on creating a comprehensive data repository that consolidates pharmacological data related to HIV treatment and prevention. It aims to enhance the accessibility and usability of over 75,000 unique data points from various studies, which quantify the effects of antiretroviral drugs. By applying principles that ensure the data is findable, accessible, interoperable, and reusable, the project seeks to facilitate biomedical research and accelerate the discovery of new therapeutic strategies for HIV. Patients may benefit from improved treatment options as researchers utilize this data to inform their studies.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective HIV treatments and prevention strategies.

How similar studies have gone: Other research initiatives utilizing data repositories for pharmacological data have shown success in advancing treatment options, indicating that this approach is promising.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Cottrell, Mackenzie — Univ of North Carolina Chapel Hill
  • Study coordinator: Cottrell, Mackenzie

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.